BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 37865988)

  • 1. Chronic wound-related pain, wound healing and the therapeutic potential of cannabinoids and endocannabinoid system modulation.
    Healy CR; Gethin G; Pandit A; Finn DP
    Biomed Pharmacother; 2023 Dec; 168():115714. PubMed ID: 37865988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoids and the endocannabinoid system in fibromyalgia: A review of preclinical and clinical research.
    Bourke SL; Schlag AK; O'Sullivan SE; Nutt DJ; Finn DP
    Pharmacol Ther; 2022 Dec; 240():108216. PubMed ID: 35609718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding Cannabis-Based Therapeutics in Sports Medicine.
    Maurer GE; Mathews NM; Schleich KT; Slayman TG; Marcussen BL
    Sports Health; 2020; 12(6):540-546. PubMed ID: 32936058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies.
    Finn DP; Haroutounian S; Hohmann AG; Krane E; Soliman N; Rice ASC
    Pain; 2021 Jul; 162(Suppl 1):S5-S25. PubMed ID: 33729211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-based Potential Therapeutic Applications of Cannabinoids in Wound Management.
    Kibret BG; Patel S; Niezgoda J; Guns W; Niezgoda J; Gopalakrishnan S; Baban B; Cubillos P; Villeneuve D; Kumar P
    Adv Skin Wound Care; 2022 Aug; 35(8):447-453. PubMed ID: 35588193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The therapeutic potential of cannabinoids for integumentary wound management.
    Weigelt MA; Sivamani R; Lev-Tov H
    Exp Dermatol; 2021 Feb; 30(2):201-211. PubMed ID: 33205468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoids in the management of chronic pain: a front line clinical perspective.
    Lynch ME
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):189-91. PubMed ID: 26581068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The endocannabinoid system and related lipids as potential targets for the treatment of migraine-related pain.
    Greco R; Demartini C; Zanaboni AM; Francavilla M; De Icco R; Ahmad L; Tassorelli C
    Headache; 2022 Mar; 62(3):227-240. PubMed ID: 35179780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the endocannabinoid system to treat anxiety-related disorders.
    Korem N; Zer-Aviv TM; Ganon-Elazar E; Abush H; Akirav I
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):193-202. PubMed ID: 26426887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous endocannabinoid system: Does it have a role on skin wound healing bearing fibrosis?
    Correia-Sá I; Paiva A; Carvalho CM; Vieira-Coelho MA
    Pharmacol Res; 2020 Sep; 159():104862. PubMed ID: 32454223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system.
    Aymerich MS; Aso E; Abellanas MA; Tolon RM; Ramos JA; Ferrer I; Romero J; Fernández-Ruiz J
    Biochem Pharmacol; 2018 Nov; 157():67-84. PubMed ID: 30121249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical Use of Cannabinoids.
    Fraguas-Sánchez AI; Torres-Suárez AI
    Drugs; 2018 Nov; 78(16):1665-1703. PubMed ID: 30374797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocannabinoid System: A Multi-Facet Therapeutic Target.
    Kaur R; Ambwani SR; Singh S
    Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of cannabinoids on wound healing: A review.
    Parikh AC; Jeffery CS; Sandhu Z; Brownlee BP; Queimado L; Mims MM
    Health Sci Rep; 2024 Feb; 7(2):e1908. PubMed ID: 38410495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward a translational approach to targeting the endocannabinoid system in posttraumatic stress disorder: a critical review of preclinical research.
    Papini S; Sullivan GM; Hien DA; Shvil E; Neria Y
    Biol Psychol; 2015 Jan; 104():8-18. PubMed ID: 25448242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy.
    Rice AS; Farquhar-Smith WP; Nagy I
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):243-56. PubMed ID: 12052040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain.
    Burns TL; Ineck JR
    Ann Pharmacother; 2006 Feb; 40(2):251-60. PubMed ID: 16449552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoids, endocannabinoids, and cancer.
    Hermanson DJ; Marnett LJ
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):599-612. PubMed ID: 22038019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome.
    Brierley SM; Greenwood-Van Meerveld B; Sarnelli G; Sharkey KA; Storr M; Tack J
    Nat Rev Gastroenterol Hepatol; 2023 Jan; 20(1):5-25. PubMed ID: 36168049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoids and Pain: Sites and Mechanisms of Action.
    Starowicz K; Finn DP
    Adv Pharmacol; 2017; 80():437-475. PubMed ID: 28826543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.